Rare diseases
Investigational molecules
Locations
Saint Kevins, 10 Earlsfort Terrace, D02 T380 Dublin, Ireland
Clinuvel Europe Limited focuses on clinical research in erythropoietic protoporphyria (EPP), with attention to the use of afamelanotide in patients across adolescent and adult age groups. This area reflects interest in conditions linked to light sensitivity and the biological response to ultraviolet radiation.
The sponsor also supports research examining skin DNA damage and DNA repair capacity in healthy volunteers, extending its therapeutic interest into human skin biology and light-induced cellular injury.
Clinuvel Europe Limited runs clinical trials in conditions such as Parkinson's disease, Porphyria non-acute, Ischaemic stroke, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanySafety Study of Afamelanotide for Patients with Early Parkinson's Disease
ItalyStudy of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)
BelgiumStudy on the Safety and Effects of Afamelanotide for Patients with Early Parkinson's Disease
SpainStudy on the Safety of Afamelanotide for Patients with Acute Arterial Ischemic Stroke Ineligible for Standard Stroke Treatments
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
